Wegovy is currently available in the U.S. as an injectable medication, with the shortage officially declared over in February 2025. A new oral version of Wegovy (25 mg pill) is expected to be approved by the FDA by the end of 2025, but an exact availability date has not been announced yet. Additionally, a higher dose (7.2 mg) of Wegovy is expected to be available in Europe by late 2025 or early 2026, but U.S. availability for this dose remains uncertain. Summary of availability:
- Injectable Wegovy: Available now, shortage declared over as of February 2025.
- Oral Wegovy pill (25 mg): FDA approval expected late 2025, availability date not yet confirmed.
- Higher dose Wegovy (7.2 mg): Expected in Europe late 2025/early 2026; U.S. approval status not clear.
No generic versions of Wegovy are currently available due to patent protections, with expiration dates likely beyond 2026. These updates indicate that Wegovy is available now in injectable form, with new forms and doses coming soon but not immediately available yet.
